Prevalence of Serum Antibodies Against Vaccine-Preventable Diseases in Students of A Japanese University of Health and Welfare and its Advisory Standard of Vaccination for Clinical Training

Kei Numazaki 1, Aya Inoue 1, Wei-wei Wang 1
More Detail
1 Division of International Infectious Diseases, Graduate School of Health and Welfare, International University of Health and Welfare
EUR J BASIC MED SCI, Volume 3, Issue 3, pp. 50-55.
Download Full Text (PDF)


The incidence of vaccine preventable diseases has increased in the adult Japanese population. The purpose of this study was to determine the need for vaccinations in students of co-medical field. Status of the students attending to International University of health and welfare, Japan were surveyed in 2008 to 2011 academic year for vaccination and past medical history by self-administered questionnaire and the serum antibody prevalence for enrollment concerning measles, rubella, varicella and mumps. Majority of the students in all years had immunity for measles, rubella and varicella but not for mumps by EIA assy. Although positive rates of measles antibody had risen since 2009, which of rubella was extremely low in the year of 2011. Serum antibody titers of rubella were lower than those of measles in all years. Freshman of 2008 showed highest antibody titers against measles and rubella. These results suggest that the forth stage of measles and rubella mixed regular vaccination targeted since 2008 in Japan was effective. Also determined what should be done the encouraging vaccination based on specific past medical history, vaccination histories (including dates and times) about encouraging vaccination, appropriate for the individual.


Numazaki K, Inoue A, Wang WW. Prevalence of Serum Antibodies Against Vaccine-Preventable Diseases in Students of A Japanese University of Health and Welfare and its Advisory Standard of Vaccination for Clinical Training. Eur J Basic Med Sci. 2013;3(3):50-5.


  • CDC. Immunization of Health-Care Personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 2011; 60 (7): 10-25.
  • Davis RM, Orenstein WA, Frank JA Jr, Sacks JJ, Dales LG, Preblud SR, Bart KJ, Williams NM, Hinman AR . Transmission of measles in medical settings. 1980 through 1984. JAMA 1986; 255(10): 1295-8.
  • Numazaki K. Current problems of measles control in Japan and western pacific region. Vaccine 2007; 25: 3101-4.
  • World Health Organization. Global elimination of measles EXECUTIVE BOARD EB125/4 125th Session 1 Provisional agenda item 5.1, 2009.
  • Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101-10.
  • Mathias RG, Meekison WG, Arcand TA, Schechter MA. The role of secondary vaccine failures in measles outbreaks. Am J Public Health 1989;79:475-8.
  • Edmonson MB, Davis JP, Hopfensperger DJ, Berg JL, Payton LA. Measles vaccination during the respiratory virus season and risk of vaccine failure. Pediatrics 1996;98:905-10.
  • Hasegawa T, Asaeda A , Hamaguchi Y, Numazaki K. Development of rapid diagnostic reagent for measles. Hybridoma 2009;28:241-9.
  • Numazaki K. A study on the clinical application of a rapid diagnostic reagent for measles. Eur J Gen Med 2012; 9;39-44.
  • Falk WA, Buchan K, Dow M, et al. The epidemiology of mumps in Southern Alberta, 1980-1982. Am J Epidemiol 1989;130:736-49.
  • CDC. Mumps surveillance, January 1977-December 1982. Atlanta, US Department of Health and Human Services, US Public Health Service, 1984.
  • Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control 2003; 31(3): 157-62.
  • Ikeda Y, Noda J, Inoue Y, Isogai N. Seroprevalence survey of measles, mumps, rubella and varicella antibodies and measles vaccination in Japanese health care workers. European Journal of Health 2013;1:1-10.
  • Grabowsky M, Markowitz L. Serologic screening, mass immunization, and implications for immunization programs {letter}. J Infect Dis 1991;164:1237-8.